Farmabase

What Farmabase does

Farmabase is a Brazilian veterinary pharmaceutical manufacturer founded in 1994 that develops and produces health products for poultry and swine. The company is headquartered in Jaguariúna, São Paulo, and serves animal protein producers across more than 50 countries through owned subsidiaries in Argentina (CEVASA, acquired 2017), Mexico, the Caribbean, and China, complemented by a global distributor network. Its portfolio spans six categories—therapeutics, systemic antibiotics, anticoccidials, antiparasitics, biosecurity, and health & performance—with over 80 products administered via feed, drinking water, injection, and topical application, alongside selective extensions into cattle and equine segments.

The company manufactures in ISO Class 7 and 8 clean rooms with a proprietary total traceability system that enables online control of the production chain from suppliers to end consumer. Farmabase operates internal R&D laboratories staffed by pharmacists, chemists, and veterinarians for analytical method development and formulation work. It was the first veterinary drug manufacturer in Brazil to obtain GMP certification (2014), holds ISO 9001 (since 2006) and Codex Alimentarius HACCP (2023) certifications, and is approved by the largest animal protein producers and exporters in Brazil. The company has held market leadership in Brazil's antimicrobial segment for poultry and pork since 2012 and consolidated poultry and pork segment leadership by 2015.

Farmabase operates a B2B enterprise field-sales model, selling directly to large animal protein producers and exporters in core markets and through distributors in the remaining geographies. Marketing is technical in nature—delivered via the PAT (Technical Assistance Program), customer-visit programs at its Jaguariúna headquarters, and a multilingual digital presence. The company is privately held with no disclosed external funding rounds; revenue is generated from product sales across the veterinary pharmaceutical portfolio with no public pricing disclosure.

Name

Farmabase

Legal name

Farmabase

Website

https://farmabase.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

Farmabase is a Brazilian veterinary pharmaceutical manufacturer founded in 1994 that develops and sells antibiotics, anticoccidials, antiparasitics, biosecurity, therapeutics, and health supplements for poultry and swine producers across 50+ countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Agricultural Services (700)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Antimicrobials & Anti-infectives (HLAMAEAE), Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Swine Veterinary Services (HLAMABAB), Livestock & Farm Animal Veterinary Services (AFAEANAB), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Poultry medications
• Swine health products
• Livestock antibiotics

Headquarters

HQ city

Jaguariúna

HQ country

Brazil

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Veterinary Pharmaceutical Products: Farmabase manufactures and sells a broad portfolio of medications for poultry and swine health, including systemic, enteric, anticoccidial, antiparasitic, biosecurity, and therapeutic products. Products are administered via feed, drinking water, and injectable routes.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Farmabase manufactures and sells veterinary pharmaceuticals for the prevention and treatment of diseases in poultry and swine, including systemic antibiotics, anticoccidials, antiparasitics, therapeutics, biosecurity disinfectants, and health & performance products. Products are administered via feed, drinking water, and injectable routes and are technically approved by the largest animal protein producers and exporters in Brazil. The company distributes to over 50 countries through direct sales, regional subsidiaries, and an international distributor network.

Product overview

Farmabase is a Brazilian animal health company specializing in veterinary pharmaceuticals for poultry and swine, with over 28 years of history. The company offers a comprehensive portfolio organized into six main product categories: Therapeutics (anti-inflammatory, analgesic, and antipyretic products including PROFENAC, DEXABASE, DIPIREX, DICLOBASE, and ANTITERMYL lines), Systemic Antibiotics (over 40 products including amoxicillin, doxycycline, florfenicol, enrofloxacin, norfloxacin, tilmicosin, tiamulin, tulathromycin, and colistin formulations), Antiparasitics (anthelmintics including VERMINASE, IVERBASE, OXYVERM, FLUBENBASE, and CONTROLVERM products), Anticoccidials (COXIFARM ionophore and chemical products, AMPROLBASE, SULFABASE, FARMACOX, ZOOCOX, and RUMITEC), Biosecurity (VIRUKILL disinfectants, FARMASEPT product line, ECONAFARM antifungal, and CYDEX larvicide), and Health & Performance (VITAMINASE supplements, SUIGEST estrus synchronization, Hi-GROW and H-MAX performance enhancers, and ENRAMAX intestinal health products). Products are administered via feed, drinking water, injection, and topical application, serving the poultry and swine production industries globally in over 50 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Systemic Antibiotics Portfolio (FARMAXILIN, FARMADOX, FARMAFLOR, FARMAFLOX, ENROFARM, BIOCEF, BACTROGEN, APRAMIX, BACTROFÓS, HI-BAC, NEOBASE, NEOCOL, LINCOFARM, SPECTOMIX, PROMOTIN, OXIBAC, ROVAX, SUPRAMULIN, TREOXIN, STARK, TRIMECLOR, TRIMETOX, CONTROLBAC, CIPRONIL, NORFLOXACIN, AMOXICEV, T-GROW) Broad-spectrum systemic antibiotics for treatment of respiratory, enteric, and systemic bacterial infections in poultry and swine, available as oral powders, oral solutions, premixes, and injectables.
• Anticoccidial Portfolio (COXIFARM line, AMPROLBASE, SULFABASE, FARMACOX, ZOOCOX, RUMITEC M200) Anticoccidial medications for prevention and treatment of coccidiosis in broiler chickens, replacement pullets, piglets, and calves, including ionophore and chemical classes with various withdrawal period profiles.
• Antiparasitic Portfolio (CONTROLVERM, FLUBENBASE, IVERBASE, OXYVERM, VERMINASE) Single-dose and water-soluble anthelmintics and antiparasitics for control of flatworms, roundworms, tapeworms, endoparasites and ectoparasites in poultry and swine, administered via feed or drinking water.
• Therapeutic Portfolio (PROFENAC, DEXABASE, DIPIREX, DICLOBASE, ANTITERMYL) Anti-inflammatory, analgesic, and antipyretic medications containing ketoprofen, dexamethasone, sodium dipyrone, sodium diclofenac, and paracetamol for supportive treatment of inflammatory, pain, and fever conditions in pigs, cattle, and horses.
• Biosecurity Portfolio (VIRUKILL, FARMASEPT 40/500/800/Plus, ECONAFARM, CYDEX) Broad-spectrum disinfectants, antifungals, and larvicides based on quaternary ammonium, glutaraldehyde, DDAC, benzalkonium chloride, econazole, and cyromazine for facility disinfection, drinking water sanitation, hatcheries, slaughterhouses, vehicles, and continuous fly control.
• Health & Performance Portfolio (VITAMINASE, SUIGEST, Hi-GROW, H-MAX, ENRAMAX, BACIMIX) Electrolyte, mineral, and polyvitamin supplements (VITAMINASE), estrus synchronization (SUIGEST), performance enhancers (Hi-GROW, BACIMIX, H-MAX), and intestinal health products (ENRAMAX) supporting feed conversion, growth, and reproductive management in poultry and swine.

Quantifiable outcome

• First GMP certified veterinary drug industry in Brazil (2014)
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• CEVASA (Argentina)coreStrategic or Co-development Partner · 1 January 2017Farmabase acquired the Argentine company CEVASA (Farmabase Salud Animal) in 2017, broadening its horizons and accelerating its process of global expansion. CEVASA operates as a subsidiary in Argentina with office in Buenos Aires.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Hipra: Spanish animal health company specializing in vaccines and pharmaceuticals for livestock, with growing Latin American presence. Comparable in species focus (poultry and swine) and in offering alternatives to traditional antimicrobials.

Direct peers

• Virbac: French veterinary pharmaceutical manufacturer with strong presence in livestock pharmaceuticals across Latin America and emerging markets. Directly comparable in product categories (antibiotics, parasiticides, therapeutics) and customer segments.
• Ceva Santé Animale: French global animal health company offering a comparable portfolio of pharmaceuticals, vaccines, and biosecurity solutions for poultry and swine across emerging and developed markets. Closely aligned business model serving the same livestock producer customer base.
• Vetoquinol: Independent French veterinary pharmaceutical company with a portfolio covering anti-infectives, parasiticides, and anti-inflammatory products for livestock. Comparable mid-sized competitor focused on production animal health.
• Ourofino Saúde Animal: Brazilian animal health company manufacturing pharmaceuticals, vaccines, and biological products for livestock and companion animals. Most direct domestic competitor sharing the same Brazilian customer base and distribution channels.

Broad incumbents

• Elanco Animal Health: Major global animal health company with a broad portfolio including livestock antibiotics, parasiticides, and feed additives. Overlaps directly with Farmabase's core therapeutic categories in poultry and swine.
• Phibro Animal Health: US-based animal health and nutrition company focused on livestock pharmaceuticals, vaccines, and feed additives. Comparable product mix with emphasis on production animal health and global distribution.
• MSD Animal Health: Animal health division of Merck offering a comprehensive portfolio of pharmaceuticals and biologics for livestock and companion animals. Major competitor in poultry and swine health categories.
• Zoetis: World's largest animal health company offering pharmaceuticals, vaccines, diagnostics, and genetic tests across all major livestock species. Competes with Farmabase on every category but operates at much greater scale and R&D intensity.
• Boehringer Ingelheim Animal Health: Top-tier global animal health business with strong positions in livestock vaccines and pharmaceuticals. Competes with Farmabase for the same large animal protein producer customers, especially in swine respiratory and poultry.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmabase